Boston Business Journal (blog) |
Intarcia makes first acquisition in quest for novel diabetes treatment
Boston Business Journal (blog) Boston biotech Intarcia Therapeutics Inc. has announced plans to acquire North Carolina-based startup Phoundry Pharmaceuticals Inc., a deal that will broaden Intarcia's development of type 2 diabetes and obesity treatments. The acquisition, the first … Intarcia acquires diabetes and obesity firm Phoundry PharmaceuticalsThe Pharma Letter (registration) Intarcia Acquiring Phoundry PharmaceuticalsGenetic Engineering & Biotechnology News Intarcia Announces AcquisitIon of Phoundry Pharmaceuticals – Second Pipeline …Virtual Press Office (press release) all 12 news articles » |
More details can be found at www.diabeteshowto.com
Discussion
Comments are disallowed for this post.
Comments are closed.